Midkine's Role in Reducing Amyloid Plaques in Alzheimer's Disease
Author Information
Author(s): Hisako Muramatsu, Katsunori Yokoi, Lan Chen, Keiko Ichihara-Tanaka, Terutoshi Kimura, Takashi Muramatsu
Primary Institution: Nagoya University Graduate School of Medicine
Hypothesis
Does midkine counteract the deposition of amyloid β-peptide plaques in Alzheimer's disease?
Conclusion
Midkine reduces the deposition of amyloid β-peptide plaques and promotes microglial migration, potentially slowing Alzheimer's disease progression.
Supporting Evidence
- Midkine binds to amyloid β-peptide with an affinity of 160 nM.
- Plaque deposition was more intense in midkine-deficient mice compared to wild-type mice.
- Midkine promotes the migration of microglia, which are involved in clearing amyloid plaques.
Takeaway
Midkine helps keep the brain healthy by stopping bad stuff from building up and helping good cells move around.
Methodology
The study used surface plasmon resonance to assess midkine's binding to amyloid β-peptide and compared plaque deposition in wild-type and midkine-deficient mice.
Limitations
The study primarily focused on mouse models, which may not fully replicate human Alzheimer's disease.
Participant Demographics
Mice used were either wild-type or genetically modified to lack midkine.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website